Light chain variable regions
US-11033634-B2 · Jun 15, 2021 · US
This page is not indexed by search engines while we improve data quality.
Stull Robert A patents
Stull Robert A is listed as an inventor on 53 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Stull Robert A |
| Total patents | 53 |
| First publication | Nov 1, 2016 |
| Latest publication | Jun 15, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-PTK7 antibodies and methods of use
US-10836831-B2 · Nov 17, 2020 · US
Anti sez6 antibodies and methods of use
US-2020181256-A1 · Jun 11, 2020 · US
Dll3 modulators and methods of use
US-2020138969-A1 · May 7, 2020 · US
Anti SEZ6 antibodies and methods of use
US-10533051-B2 · Jan 14, 2020 · US
Dll3 modulators and methods of use
US-2019247510-A1 · Aug 15, 2019 · US
Anti-dll3 drug conjugates for treating tumors at risk of neuroendocrine transition
US-2019201542-A1 · Jul 4, 2019 · US
Novel anti-claudin antibodies and methods of use
US-2019083645-A1 · Mar 21, 2019 · US
Novel anti-claudin antibodies and methods of use
US-2019077876-A1 · Mar 14, 2019 · US
Dll3 modulators and methods of use
US-2019046656-A1 · Feb 14, 2019 · US
Recent patents
Latest publications not already listed above.
Novel anti-tnfsf9 antibodies and methods of use
US-2019016812-A1 · Jan 17, 2019 · US
Novel anti-upk1b antibodies and methods of use
US-2019000969-A1 · Jan 3, 2019 · US
Anti-DLL3 antibody drug conjugates for treating cancer
US-10137204-B2 · Nov 27, 2018 · US
Novel anti-emr2 antibodies and methods of use
US-2018327506-A1 · Nov 15, 2018 · US
Anti-CD324 monoclonal antibodies and uses thereof
US-10087258-B2 · Oct 2, 2018 · US
Novel modulators and methods of use
US-2018237512-A1 · Aug 23, 2018 · US
Anti-claudin antibodies and methods of use
US-10053511-B2 · Aug 21, 2018 · US
Modulators and methods of use
US-10017565-B2 · Jul 10, 2018 · US
Novel modulators and methods of use
US-2018162952-A1 · Jun 14, 2018 · US
Modulators and methods of use
US-9969798-B2 · May 15, 2018 · US
Anti-DLL3 antibody drug conjugates and methods of use
US-9937268-B2 · Apr 10, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9931421-B2 · Apr 3, 2018 · US
Methods of making DLL3 antibody drug conjugates
US-9931420-B2 · Apr 3, 2018 · US
PTK7 modulators and methods of use
US-9914784-B2 · Mar 13, 2018 · US
Anti-dll3 chimeric antigen receptors and methods of use
US-2018044415-A1 · Feb 15, 2018 · US
Methods of making dll3 antibody drug conjugates
US-2018036421-A1 · Feb 8, 2018 · US
Methods of delivering dll3 antibody drug conjugates
US-2018036422-A1 · Feb 8, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9878053-B2 · Jan 30, 2018 · US
Anti-dll3 antibody drug conjugates and methods of use
US-2018015178-A1 · Jan 18, 2018 · US
Anti-DLL3 antibody drug conjugates
US-9867887-B1 · Jan 16, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Stemcentrx Llc | 53 |
| Stemcentrx Inc | 4 |
| Stem Centrx Inc | 2 |
| AbbVie Stemcentrx LLP | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/24 | 52 |
| A61P35/00 | 50 |
| C07K2317/77 | 46 |
| C07K2317/33 | 46 |
| C07K2317/56 | 45 |